Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH).

It has been studied for its effects on pituitary growth hormone signalling, IGF-1 responses and visceral adipose tissue. The visceral-fat findings come from clinical studies involving people with HIV-associated abdominal fat accumulation.

Commonly researched areas of interest

• GHRH receptor signalling

• Growth hormone and IGF-1 responses

• Visceral adipose tissue in clinical studies

• Body composition and metabolic markers

• Relationships between hormone responses and adipose tissue changes

Tesamorelin is a synthetic analogue of growth hormone–releasing hormone (GHRH). Research has examined its effects on growth hormone and IGF-1 responses, as well as visceral adipose tissue in clinical studies involving adults with HIV-associated abdominal fat accumulation.

For research use only.